Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 18
Combined Corticosteroid and Minoxidil Therapy for Early Recovery in Radiation-Induced Alopecia: A Case Report
Received 28 February 2025
Accepted for publication 30 May 2025
Published 17 June 2025 Volume 2025:18 Pages 1495—1499
DOI https://doi.org/10.2147/CCID.S520575
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Jeffrey Weinberg
Xi Chen,* Yutong Xie,* Aihua Wei
Department of Dermatology, Beijing TongRen Hospital, Capital Medical University, Beijing, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Aihua Wei, Email [email protected]
Abstract: This case report describes a 42-year-old man who developed radiation-induced alopecia after an endovascular embolization procedure for a cerebral arteriovenous fistula. The alopecia appeared as a well-defined patch of hair loss on the right scalp, confirmed by biopsy showing lymphocytic infiltration and increased catagen and telogen follicles. The patient was treated with intramuscular corticosteroid injections and topical 5% minoxidil, leading to complete hair regrowth after three months. Radiation-induced alopecia, though rare and typically self-limiting, requires early diagnosis. This case highlights a novel therapeutic approach combining corticosteroids and minoxidil for faster recovery.
Keywords: radiation, alopecia, endovascular embolization, corticosteroid therapy, minoxidil
Introduction
Endovascular embolization is commonly selected as the primary treatment modality for arteriovenous fistulas and other cerebrovascular diseases, using fluoroscopy to visualize cerebrovascular lesions, followed by the embolization of the distorted vessel. However, prolonged exposure to high doses of radiation can damage the scalp skin and hair follicles. Radiation-induced alopecia represents one of the rare complications linked to these procedures. We present a typical case of radiation-induced alopecia after endovascular embolization and provide a literature review to summarize the current understanding and management strategies for this condition.
Case Report
A 42-year-old man presented to our dermatology department with a sudden patch of alopecia on the right half of his scalp, persisting for one week. Physical examination revealed approximately an alopecia patch with polygonal shape of rectangular-triangular concatenation on the right side of his scalp, involving 40% of the total scalp area (Figure 1A–C). Before the examination, the patient added that he underwent cerebral endovascular embolization treatment for a cerebral arteriovenous fistula in the quadrigeminal cistern three weeks prior (Figure 1D). Black dots, dystrophic hairs, and short vellus hairs were observed under trichoscope and no exclamation mark hair was found (Figure 2A). For further diagnosis, we conducted a scalp biopsy, and histopathology demonstrated sparse lymphocyte infiltration, with an increased proportion of catagen and telogen hair follicles (Figure 2B–F). The patient was finally diagnosed with radiation-induced alopecia after endovascular embolization. He underwent three monthly sessions of intramuscular compound betamethasone injection (1 mL per month), with topical treatment of 5% minoxidil tincture (1 mL per time, twice daily) combined with halometasone cream (appreciate amount, once daily). At the next month’s follow-up, his hair had fully regrowth (Figure 3). The patient did not report any discomfort during the treatment, and no clinical relapse was observed during the 2-year follow-up.
|
Figure 1 (A–C) Clinical images showing the hair loss affecting the right half of patient’s scalp. (D) Fluoroscopic view of the cerebral arteriovenous fistula in the quadrigeminal cistern. |
|
Figure 3 (A–D) Clinical images showing that the patient had complete hair regrowth after three-month treatment. |
Discussion
Temporary alopecia is a relatively rare complication of acute radiation syndrome and is considered a specific form of radiodermatitis.1 This occurs due to the heightened sensitivity of hair follicles to radiation exposure. Acute damage to actively dividing matrix cells of anagen follicles results in the loss of dystrophic hair. The late anagen hair prematurely transitions into catagen, followed by telogen, leading to premature hair shedding.2 Radiation-induced alopecia typically manifests 2–5 weeks after the procedure and is influenced by various factors, including radiation dose, duration, interval between irradiations, area of irradiated surface, irradiation angle, and certain patient biological factors (such as age, smoking, malnutrition, tissue oxygenation, capillary density, genetics, and ethnicity).3,4 A radiation dose of 3–6 gray results in temporary alopecia, while a dose exceeding 7 gray leads to permanent alopecia.5
Typically, radiation-induced alopecia presents with distinctive clinical features characterized by a well-defined round or rectangular alopecia patch with evenly reduced hair density. These features arise due to prolonged exposure from any single view during an endovascular embolization procedure. Trichoscopy revealed black dots, yellow dots, and dystrophic hairs, with exclamation mark hairs being rare. Histopathology showed an increased proportion of catagen and telogen hair follicles with or without inflammatory infiltration.2,6,7 The main differential diagnoses could include alopecia areata, trichotillomania and pressure-induced alopecia. In our case, the patient underwent an initial digital subtraction angiography for detecting a cerebral arteriovenous fistula in the quadrigeminal cistern, followed by endovascular embolization treatment two days later. The total duration of these procedures was 172 minutes. The medical history can aid in making the correct diagnosis straightforward. Temporary hair loss typically regrew spontaneously within 2–6 months under observation. Treatment strategies reported in the literature mainly include topical corticosteroid and minoxidil lotion. In Lee’s study, five patients presented alopecia after undergoing the procedure of intracranial aneurysm embolization. They all received treatment of superficial cryotherapy and 0.25% desoxymethasone lotion, and showed improvement after 4–5 weeks and completely recovered within 5–6 months.8 In recent years, most patients diagnosed with radiation-induced alopecia after endovascular embolization received topical minoxidil, achieving complete hair regrew within 4–5 months follow-up.1,2,9 Our case was the first to propose using systematic corticosteroid injections with topical 5% minoxidil to potentially improve outcomes. However, single case report with short follow-up was the limitation of the study.
Conclusion
Although radiation-induced alopecia is benign and self-limiting, dermatologists must promptly identify this condition and make an accurate diagnosis based on medical history and clinical features. This case presents the first successful treatment of radiation-induced alopecia after endovascular embolization using combined corticosteroid and minoxidil therapy, achieving complete hair regrowth significantly faster than single topical treatment or spontaneous recovery. Our findings suggest that radiation-induced alopecia, and may offer clinicians alternative treatment strategies for this rare complication.
Patient Consent
A formal written consent was obtained for publication the case details and associated images from the patients. No institutional approval is required to publish the case details.
Acknowledgment
We thank Dr. Chenghua Xu and Dr. Yu Xiao for the assistance on neuroradiological images analysis.
Funding
This study was funded by the National Natural Science Foundation of China (82203951).
Disclosure
The authors declare no conflicts of interest in this work.
References
1. Herrero-Moyano M, Hernández PM, Castañon PG, Monreal JLC. Transient rectangular alopecia after endovascular embolization: a case series of four patients describing dermoscopic and histopathologic findings. Int J Trichol. 2022;14(4):138–140. doi:10.4103/ijt.ijt_172_20
2. Ounsakul V, Iamsumang W, Suchonwanit P. Radiation-induced alopecia after endovascular embolization under fluoroscopy. Case Rep Dermatol Med. 2016;2016:8202469. doi:10.1155/2016/8202469
3. Podlipnik S, Giavedoni P, San-Román L, Ferrando J. Square alopecia: a new type of transient alopecia of the scalp following fluoroscopically endovascular embolization. Int J Trichol. 2013;5(4):201–203. doi:10.4103/0974-7753.130406
4. Kaushal A, Bindra A, Singh S, Sameera V. Single sitting of cerebral endovascular procedure causing alopecia. Int J Trichol. 2018;10(3):145–146. doi:10.4103/ijt.ijt_11_18
5. Nannapaneni R, Behari S, Mendelow D, Gholkar A. Temporary alopecia after subarachnoid haemorrhage. J Clin Neurosci. 2007;14(2):157–161. doi:10.1016/j.jocn.2005.12.031
6. Cho S, Choi MJ, Lee JS, Zheng Z, Kim DY. Dermoscopic findings in radiation-induced alopecia after angioembolization. Dermatology. 2014;229(2):141–145. doi:10.1159/000362810
7. Bernárdez C, Alcaraz I, Molina-Ruiz AM, Requena L. Transitory rectangular alopecia after endovascular embolization: a case report and description of the histopathology findings. Actas Dermosifiliogr. 2015;106(10):848–850. doi:10.1016/j.ad.2015.06.006
8. Lee WS, Lee SW, Lee S, L JW. Postoperative alopecia in five patients after treatment of aneurysm rupture with a Guglielmi detachable coil: pressure alopecia, radiation induced, or both? J Dermatol. 2004;31(10):848–851. doi:10.1111/j.1346-8138.2004.tb00614.x
9. Lee H, Lee S, Lee YB, Lee WS. Radiation-induced rectangular alopecia after endovascular embolization of cerebral aneurysms: the necessity of a comprehensive study on its incidence and critical radiation doses. Ann Dermatol. 2019;31(Suppl):S24–S6. doi:10.5021/ad.2019.31.S.S24
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Recommended articles
Refractory Folliculitis Decalvans Treatment Success with a Novel Surgical Excision Approach Using Guarded High-Tension Sutures
Umar S, Waterman A, Ton D, Shitabata P
Clinical, Cosmetic and Investigational Dermatology 2023, 16:2381-2390
Published Date: 1 September 2023
Patient Reported Outcomes and Treatment-Associated Complications as a Consideration in Selecting Localized Prostate Cancer Management
Nguyen T, Lightfoot C, May D, Greenberg JW, Krane LS
Research and Reports in Urology 2025, 17:195-210
Published Date: 12 June 2025
